Egyptian Drug Authority License
FRC was licensed by the Egyptian Drug Authority (EDA) to perform bioequivalence/ bioavailability and stability studies since 2019.
Iraq Ministry of Health Approval
FRC was licensed by the Egyptian Drug Authority (EDA) to perform bioequivalence studies since after successfully passing the inspection visit in October 2023.
GCC Approved Bioequivalence Center
FRC has successfully passed GCC inspection and approved by GHC to be added to the List of GCC Approved bioequivalence centers worldwide in September 2026.
GCP & GLP Certification by EDA
FRC was granted certificates of compliance with the Good Clinical Practices (GCP) & Good Laboratory Practices (GLP) by the Egyptian Drug Authority (EDA) after successfully passing the annual inspection visit in November 2020, and has been renewed in March 2026.
GLP AND GCP CERTIFICATE
FRC quality management system has been approved by Certiva
FRC quality management system has been approved by Certiva and is compliant with the requirements of ISO 9001:2015
ISO 9001:2015 Certificate